• Differentiation of human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) into cardiovascular cells, including cardiomyocytes (CMs) and endothelial cells (ECs)
  • Development of hiPSC-based cardiovascular disease models
  • Molecular mechanisms of cardiovascular diseases using hiPSC-CMs and hiPSC-ECs
  • Drug developmentand screening using patient-specific hiPSC-CMs and hiPSC-ECs
  • Cardiac electrophysiology and pharmacology using hESC- and hiPSC-CMs

Last Modified: Dec 23, 2014

Page Views: 1208

Comments are closed.